Latest Breaking News On - Gillian woollett - Page 1 : comparemela.com

for those of you looking to catch-up on biosimilars in 2020 and what these experts are most excited about for the year(s) ahead. As the Editorial Board explores which challenges are ahead for 2021, it’s reassuring to note that sustainability is increasingly entering the U.S. biosimilars conversation. As you’ll note in this installment, there are several particularly passionate calls-to-action for companies to confront misinformation, collaborate with stakeholders, and to refine their commercial business models in the name of greater market efficiency. Though there is a lot to be done, it’s clear from these answers that stakeholders are relying more heavily on biosimilars and that it’s more important than ever for biosimilar companies to keep carrying the torch for more competition, cost-savings, value, and responsible pricing.  

Kathy oubreTiffany fletcherEdric engertHillel cohenMatthew harmanGillian woollettNed pojskicFrancois xavier frapaiseAnna rose welchBrian lehmanNoelle sunstromSean mcgowanJulie reedJulie marAvalere healthPontchartrain cancer center